Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Toulouse
VA Office of Research and Development
Chinese University of Hong Kong
University of Colorado, Denver
Brigham and Women's Hospital
Jinling Hospital, China
NiKang Therapeutics, Inc.
Pfizer
Centre of Postgraduate Medical Education
University of Alabama at Birmingham
University of Waterloo
Rigshospitalet, Denmark
Guangzhou Red Pine Medical Instrument Co., Ltd.
University Hospital, Ghent
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Technical University of Munich
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Michigan
University Health Network, Toronto
Taiho Oncology, Inc.
University of Waterloo
Sanguine Biosciences
University Medical Center Groningen
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Population Health Research Institute
Milton S. Hershey Medical Center
Aravive, Inc.
Columbia University
Audubon Bioscience
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Ain Shams University
Meddoc
Université de Sherbrooke
University of Liege
Radboud University Medical Center
Pfizer
Centre Hospitalier Régional d'Orléans
Butantan Institute
Celldex Therapeutics
Vanderbilt University Medical Center
University Hospital, Bordeaux
Celldex Therapeutics
Celldex Therapeutics
Amgen
Peking Union Medical College Hospital
Ottawa Hospital Research Institute
Stanford University
Merck Sharp & Dohme LLC